Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure
- 1 November 2017
- journal article
- letter
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 196 (9), 1222-1224
- https://doi.org/10.1164/rccm.201612-2585le
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Treatment Outcomes in Multidrug-Resistant TuberculosisNew England Journal of Medicine, 2016
- Beyond multidrug-resistant tuberculosis in Europe: a TBNET studyThe International Journal of Tuberculosis and Lung Disease, 2015
- Multidrug-Resistant Tuberculosis in Europe, 2010–2011Emerging Infectious Diseases, 2015
- Relapse more common than reinfection in recurrent tuberculosis 1–2 years post treatment in urban UgandaThe International Journal of Tuberculosis and Lung Disease, 2013
- Time until Relapse in Tuberculosis Treatment Trials: Implication for Phase 3 Trial DesignAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997.European Respiratory Journal, 2000